Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015416.5(LETMD1):c.17T>C(p.Val6Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
LETMD1 (HGNC:24241): (LETM1 domain containing 1) This gene encodes a mitochondrial outer membrane protein. It has a potential role in tumorigenesis, which may result from negative regulation of the p53 tumor suppressor gene. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Aug 2011]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.17T>C (p.V6A) alteration is located in exon 1 (coding exon 1) of the LETMD1 gene. This alteration results from a T to C substitution at nucleotide position 17, causing the valine (V) at amino acid position 6 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);Gain of catalytic residue at W8 (P = 0);